Tyrosine kinase inhibitors as cancer therapy

被引：6
作者：
Nichols, GL
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Med, Div Hematol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Med, Div Oncol, New York, NY 10032 USA
来源：
CANCER INVESTIGATION | 2003年 / 21卷 / 05期
关键词：
tyrosine kinases; signal transduction; tyrosine kinase inhibitors; cancer therapy;
D O I：
10.1081/CNV-120023774
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：758 / 771
页数：14
相关论文
共 50 条
  • [21] The Relationship between IGF Pathway and Acquired Resistance to Tyrosine Kinase Inhibitors in Cancer Therapy
    Peng, Yanjing
    Tan, Jinjing
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (08):
  • [22] Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer
    Yang, Xue
    Wu, Dapeng
    Yuan, Shengli
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [23] Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
    Qin, Shuang
    Li, Anping
    Yi, Ming
    Yu, Shengnan
    Zhang, Mingsheng
    Wu, Kongming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [24] Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond
    Bologna, M.
    Vicentini, C.
    Muzi, P.
    Pace, G.
    Angelucci, A.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (19) : 2827 - 2835
  • [25] Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
    Pytel, Dariusz
    Sliwinski, Tomasz
    Poplawski, Tomasz
    Ferriola, Deborah
    Majsterek, Ireneusz
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (01) : 66 - 76
  • [26] Tyrosine Kinase Inhibitors: The First Decade
    Agrawal, Meetu
    Garg, Ravin J.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (02) : 70 - 80
  • [27] The receptor tyrosine kinase ROR1-An oncofetal antigen for targeted cancer therapy
    Hojjat-Farsangi, Mohammad
    Moshfegh, Ali
    Daneshmanesh, Amir Hossein
    Khan, Abdul Salam
    Mikaelsson, Eva
    Osterborg, Anders
    Mellstedt, Hakan
    SEMINARS IN CANCER BIOLOGY, 2014, 29 : 21 - 31
  • [28] Ocular Toxicity of Tyrosine Kinase Inhibitors
    Davis, Mary Elizabeth
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 235 - 243
  • [29] Tyrosine Kinase Inhibitors: The First Decade
    Meetu Agrawal
    Ravin J. Garg
    Jorge Cortes
    Alfonso Quintás-Cardama
    Current Hematologic Malignancy Reports, 2010, 5 : 70 - 80
  • [30] Focus on resistance to tyrosine kinase inhibitors in renal cancer
    Falkowski, Sabrina
    BULLETIN DU CANCER, 2018, 105 : S255 - S260
12345